ETS1 (Protein C-ets-1) variants and mutations
ETS1 (also known as Protein C-ets-1) is a human protein-coding gene encoding a protein C-ets-1 protein. It regulates transcriptional programs involved in lymphocyte development, immune activation, angiogenesis, and cell differentiation. Altered dosage or activity contributes to autoimmunity and cancer, particularly through disturbed immune-cell and growth-control programs. This analysis covers 528 ETS1 variants and mutations. Of these, 61% have computational variant effect predictions. Disease context includes type 2 diabetes mellitus, systemic lupus erythematosus, and psoriasis. Example ETS1 variants include M1?, K2N, and A4V.
Variant analysis overview
- Gene: ETS1
- Protein: Protein C-ets-1
- UniProt accession: P14921
- Organism: Homo sapiens
- Variants analyzed: 528
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 237 unspecified-consequence records; 2 stop lost; 196 missense variants; 77 synonymous variants; 4 stop-gained variants; 1 splice-region variants; 10 frameshift variants; 1 substitution
- Prediction scores: 322 variants have prediction scores (61% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: type 2 diabetes mellitus, systemic lupus erythematosus, psoriasis, rheumatoid arthritis, neurodegenerative disease, celiac disease, atopic eczema, open-angle glaucoma, Eczematoid dermatitis, kidney failure, psoriasis vulgaris, glaucoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 12 post-translational modification sites.
- Structural context: 57 variants have structural context.
- PTM context: 14 variants overlap post-translational modification sites.
- Experimental data: 81 protein positions have experimental scores. Source: ETS1 Pointed domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ETS1 variants
Examples include M1?, K2N, A4V, V5F, D6N, K8R, P9A, P9L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV60095, cosmic curated COSV10740, cosmic curated COSV10440, cosmic curated COSV60098
- K2N (p.Lys2Asn), cosmic curated COSV60092, MetaLR 0.14, MetaSVM -0.89
- A4V (p.Ala4Val), cosmic curated COSV60096, MetaLR 0.18, MetaSVM -0.91
- V5F (p.Val5Phe), cosmic curated COSV10463
- D6N (p.Asp6Asn), cosmic curated COSV60092, REVEL 0.08, MetaLR 0.04
- K8R (p.Lys8Arg), cosmic curated COSV60098
- P9A (p.Pro9Ala), NCI-TCGA Cosmic COSV6009, Variant assessed as somatic; moderate impact.
- P9L (p.Pro9Leu), cosmic curated COSV60093
- P9Q (p.Pro9Gln), cosmic curated COSV10009
- P9S (p.Pro9Ser), cosmic curated COSV60095, gnomAD rs1345726211, MetaLR 0.23, MetaSVM -0.81
- T10S (p.Thr10Ser), cosmic curated COSV10590
- T12N (p.Thr12Asn), cosmic curated COSV10740, MetaLR 0.25, MetaSVM -0.80
- T12S (p.Thr12Ser), cosmic curated COSV60091
- E17K (p.Glu17Lys), cosmic curated COSV60099, 1000Genomes rs200525200, ExAC rs200525200, gnomAD rs200525200, MetaLR 0.18, MetaSVM -0.87
- E17Q (p.Glu17Gln), cosmic curated COSV60097, 1000Genomes rs200525200, ExAC rs200525200, gnomAD rs200525200, MetaLR 0.19, MetaSVM -0.88
- D20N (p.Asp20Asn), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60096, Variant assessed as somatic; moderate impact.
- E22D (p.Glu22Asp), cosmic curated COSV60096, ExAC rs765035333, gnomAD rs765035333, MetaLR 0.08, MetaSVM -1.02
- E22K (p.Glu22Lys), NCI-TCGA TCGA novel, MetaLR 0.10, MetaSVM -0.95, Variant assessed as somatic; moderate impact.
- L23F (p.Leu23Phe), cosmic curated COSV60094, gnomAD rs1202062176, MetaLR 0.08, MetaSVM -1.07
- L23V (p.Leu23Val), cosmic curated COSV10440, MetaLR 0.05, MetaSVM -1.00
- F24S (p.Phe24Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P25L (p.Pro25Leu), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, Ensembl rs1863684457, Variant assessed as somatic; moderate impact.
- P27S (p.Pro27Ser), cosmic curated COSV10590, REVEL 0.05, MetaLR 0.03
- D28N (p.Asp28Asn), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, MetaLR 0.05, MetaSVM -1.11, Variant assessed as somatic; moderate impact.
- M29V (p.Met29Val), cosmic curated COSV10009
- E30K (p.Glu30Lys), cosmic curated COSV10518
- C31* (p.Cys31Ter), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; high impact.
- C31R (p.Cys31Arg), rs942858152, []
- D33G (p.Asp33Gly), cosmic curated COSV60094, 1000Genomes rs187450978, ExAC rs187450978, TOPMed rs187450978
- V34F (p.Val34Phe), cosmic curated COSV10463
- V34I (p.Val34Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V34L (p.Val34Leu), cosmic curated COSV10610
- P35L (p.Pro35Leu), cosmic curated COSV60095
- P39S (p.Pro39Ser), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- S40N (p.Ser40Asn), cosmic curated COSV60095
- E43* (p.Glu43Ter), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; high impact.
- M44I (p.Met44Ile), cosmic curated COSV60092
- M45I (p.Met45Ile), cosmic curated COSV60096, Ensembl rs1056567882
- M45K (p.Met45Lys), cosmic curated COSV10965, Ensembl rs1862767514
- S46F (p.Ser46Phe), cosmic curated COSV10518
- Q47* (p.Gln47Ter), cosmic curated COSV60097
- Q47E (p.Gln47Glu), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60095, Variant assessed as somatic; moderate impact.
- A51S (p.Ala51Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A51T (p.Ala51Thr), cosmic curated COSV10942
- G55C (p.Gly55Cys), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- T57S (p.Thr57Ser), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60091, Variant assessed as somatic; moderate impact.
- R62* (p.Arg62Ter), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60094, Variant assessed as somatic; high impact.
- R62Q (p.Arg62Gln), cosmic curated COSV10518, ExAC rs763404863, TOPMed rs763404863, gnomAD rs763404863
- P66L (p.Pro66Leu), cosmic curated COSV10518, ExAC rs770028412, gnomAD rs770028412
- P66S (p.Pro66Ser), cosmic curated COSV10518
- D68Y (p.Asp68Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P69F (p.Pro69Phe), cosmic curated COSV10518
- R70L (p.Arg70Leu), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, Variant assessed as somatic; moderate impact.
- R70Q (p.Arg70Gln), cosmic curated COSV60093, ExAC rs773557919, TOPMed rs773557919, gnomAD rs773557919, Uncertain significance, not specified
- R70W (p.Arg70Trp), rs375860265, NCI-TCGA Cosmic COSV1000, ESP rs375860265, TOPMed rs375860265, AlphaMissense 0.13, MetaLR 0.12, Uncertain significance, not specified
- Q71H (p.Gln71His), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, Variant assessed as somatic; moderate impact.
- T73A (p.Thr73Ala), cosmic curated COSV60095
- H76R (p.His76Arg), cosmic curated COSV10009
- V77F (p.Val77Phe), cosmic curated COSV60098
- R78L (p.Arg78Leu), cosmic curated COSV60097
- R78W (p.Arg78Trp), cosmic curated COSV10009, ExAC rs768799295, TOPMed rs768799295, gnomAD rs768799295
- W80* (p.Trp80Ter), cosmic curated COSV10518
- W83* (p.Trp83Ter), cosmic curated COSV60096
- A84G (p.Ala84Gly), cosmic curated COSV10740
- V85L (p.Val85Leu), cosmic curated COSV60097
- S89N (p.Ser89Asn), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- L90Q (p.Leu90Gln), cosmic curated COSV10009
- G92C (p.Gly92Cys), cosmic curated COSV10740
- G92V (p.Gly92Val), cosmic curated COSV60093
- V93I (p.Val93Ile), cosmic curated COSV60098
- Q96H (p.Gln96His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F98L (p.Phe98Leu), cosmic curated COSV10440
- M100I (p.Met100Ile), cosmic curated COSV60092, ExAC rs766172244, gnomAD rs766172244, Uncertain significance, not specified
- M100V (p.Met100Val), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10008, Variant assessed as somatic; moderate impact.
- G102V (p.Gly102Val), cosmic curated COSV10009
- A104T (p.Ala104Thr), cosmic curated COSV60094
- C106R (p.Cys106Arg), cosmic curated COSV10009
- A107S (p.Ala107Ser), cosmic curated COSV60097, 1000Genomes rs79963544, ESP rs79963544, ExAC rs79963544, Likely benign
- A107T (p.Ala107Thr), rs79963544, ClinGen CA6356664, cosmic curated COSV60091, ClinVar RCV000960275, AlphaMissense 0.07, MetaLR 0.09, Likely benign, not provided
- A107V (p.Ala107Val), cosmic curated COSV10440
- L108V (p.Leu108Val), cosmic curated COSV10811
- K110E (p.Lys110Glu), cosmic curated COSV60096
- D111N (p.Asp111Asn), cosmic curated COSV60098, ExAC rs764464320, gnomAD rs764464320
- C112Y (p.Cys112Tyr), cosmic curated COSV60097
- L114F (p.Leu114Phe), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- E115K (p.Glu115Lys), cosmic curated COSV10518, ESP rs374747619, ExAC rs374747619, TOPMed rs374747619, Uncertain significance, not specified
- E115Q (p.Glu115Gln), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- A117S (p.Ala117Ser), cosmic curated COSV10009
- D119N (p.Asp119Asn), cosmic curated COSV60093
- F120I (p.Phe120Ile), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; moderate impact.
- G122E (p.Gly122Glu), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60094, Variant assessed as somatic; moderate impact.
- G122W (p.Gly122Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W126* (p.Trp126Ter), cosmic curated COSV10518
- E127* (p.Glu127Ter), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; high impact.
- H128Q (p.His128Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I131M (p.Ile131Met), cosmic curated COSV60096
- K134N (p.Lys134Asn), cosmic curated COSV60094
- K134T (p.Lys134Thr), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60097, Variant assessed as somatic; moderate impact.
- E135D (p.Glu135Asp), cosmic curated COSV10009
- Y140C (p.Tyr140Cys), cosmic curated COSV10518
- G144A (p.Gly144Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V145F (p.Val145Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N146T (p.Asn146Thr), cosmic curated COSV10740, ExAC rs776702455, TOPMed rs776702455, gnomAD rs776702455
- E151D (p.Glu151Asp), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- R153C (p.Arg153Cys), cosmic curated COSV60092, ESP rs143416500, ExAC rs143416500, TOPMed rs143416500, Uncertain significance, not specified
- R153H (p.Arg153His), cosmic curated COSV60092, ExAC rs745555780, gnomAD rs745555780
- S156A (p.Ser156Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S156L (p.Ser156Leu), rs778479273, NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, ExAC rs778479273, AlphaMissense 0.22, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- D157N (p.Asp157Asn), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; moderate impact.
- Y158C (p.Tyr158Cys), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, Variant assessed as somatic; moderate impact.
- S173L (p.Ser173Leu), rs766647712, ClinGen CA6356606, NCI-TCGA Cosmic COSV6009, AlphaMissense 0.90, MetaLR 0.31, Uncertain significance, not specified
- S173W (p.Ser173Trp), rs766647712, NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, AlphaMissense 0.90, MetaLR 0.31, Uncertain significance
- E174K (p.Glu174Lys), cosmic curated COSV60091
- E177K (p.Glu177Lys), cosmic curated COSV10518
- S184F (p.Ser184Phe), cosmic curated COSV60096
- Y185S (p.Tyr185Ser), cosmic curated COSV60094
- L188F (p.Leu188Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H189Y (p.His189Tyr), cosmic curated COSV10009, ExAC rs759318033, gnomAD rs759318033
- H189H (p.His189His), gnomAD 11-128484986-A-G, CADD 8.16
- P190L (p.Pro190Leu), cosmic curated COSV10518
- P190R (p.Pro190Arg), rs540929701, NCI-TCGA Cosmic COSV6009, cosmic curated COSV60095, 1000Genomes rs540929701, AlphaMissense 0.62, MetaLR 0.23, Variant assessed as somatic; moderate impact.
- S192I (p.Ser192Ile), cosmic curated COSV10518
- S193* (p.Ser193Ter), cosmic curated COSV60096
- S193L (p.Ser193Leu), rs1565374960, NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, AlphaMissense 0.25, MetaLR 0.25, Variant assessed as somatic; moderate impact.
- S198F (p.Ser198Phe), cosmic curated COSV60097
- K200T (p.Lys200Thr), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- E202K (p.Glu202Lys), cosmic curated COSV10740
- D204G (p.Asp204Gly), cosmic curated COSV10965
- D204N (p.Asp204Asn), cosmic curated COSV10942, TOPMed rs1862586535
- Y205* (p.Tyr205Ter), cosmic curated COSV10811
- Y205N (p.Tyr205Asn), cosmic curated COSV60095
- S207L (p.Ser207Leu), rs1045241125, ClinGen CA230927536, NCI-TCGA Cosmic COSV6009, cosmic curated COSV60091, AlphaMissense 0.08, MetaLR 0.08, Uncertain significance, not specified
- S207S (p.Ser207Ser), rs1381402463, gnomAD 11-128485016-G-A, CADD 12.30
- S207A (p.Ser207Ala), rs750489144, gnomAD 11-128485027-A-C, REVEL 0.10, MetaLR 0.14
- L210F (p.Leu210Phe), cosmic curated COSV60094, ExAC rs200782788, gnomAD rs200782788
- R211* (p.Arg211Ter), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; high impact.
- D212Y (p.Asp212Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P213H (p.Pro213His), gnomAD 11-128485020-G-T, REVEL 0.23, MetaLR 0.24
- P213L (p.Pro213Leu), rs1246153557, gnomAD 11-128485020-G-A, REVEL 0.27, MetaLR 0.23
- P213T (p.Pro213Thr), rs765428803, gnomAD 11-128485021-G-T, REVEL 0.16, MetaLR 0.15
- Q215* (p.Gln215Ter), cosmic curated COSV10463
- T216I (p.Thr216Ile), rs759420818, NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, ExAC rs759420818, AlphaMissense 0.10, MetaLR 0.06, Variant assessed as somatic; moderate impact.
- D217H (p.Asp217His), NCI-TCGA Cosmic COSV1000, cosmic curated COSV10009, Variant assessed as somatic; moderate impact.
- Q220H (p.Gln220His), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60092, Variant assessed as somatic; moderate impact.
- Y223D (p.Tyr223Asp), cosmic curated COSV10463
- Y223C (p.Tyr223Cys), rs1317417666, gnomAD 11-128484999-T-C, REVEL 0.25, MetaLR 0.15
- F224L (p.Phe224Leu), gnomAD 11-128485013-G-T, REVEL 0.14, MetaLR 0.13
- I226F (p.Ile226Phe), cosmic curated COSV10645
- I226I (p.Ile226Ile), rs1862587866, gnomAD 11-128484980-G-A, CADD 12.80
- I226S (p.Ile226Ser), gnomAD 11-128484981-A-C, REVEL 0.28, MetaLR 0.12
- K227N (p.Lys227Asn), cosmic curated COSV60096
- Q228Q (p.Gln228Gln), rs1392809706, gnomAD 11-128484995-C-T, CADD 10.50
- Q228E (p.Gln228Glu), rs1398669637, gnomAD 11-128484997-G-C, REVEL 0.26, MetaLR 0.22
- E229E (p.Glu229Glu), rs527574105, gnomAD 11-128484968-C-T, CADD 2.28
- E229G (p.Glu229Gly), gnomAD 11-128485005-T-C, REVEL 0.34, MetaLR 0.23
- E229D (p.Glu229Asp), gnomAD 11-128485022-C-A, REVEL 0.09, MetaLR 0.08
- E229A (p.Glu229Ala), rs1862589784, gnomAD 11-128485032-T-G, REVEL 0.12, MetaLR 0.09
- V231A (p.Val231Ala), cosmic curated COSV10009
- V231I (p.Val231Ile), rs137970618, ClinGen CA6356572, cosmic curated COSV60097, ClinVar RCV004383119, AlphaMissense 0.19, MetaLR 0.10, Uncertain significance, not specified
- V231V (p.Val231Val), gnomAD 11-128484929-G-T, CADD 10.30
- V231F (p.Val231Phe), rs758646926, gnomAD 11-128484931-C-A, REVEL 0.22, MetaLR 0.14
- T232T (p.Thr232Thr), rs771960823, gnomAD 11-128484992-C-T, CADD 0.86
- T232K (p.Thr232Lys), gnomAD 11-128484993-G-T, REVEL 0.30, MetaLR 0.28
- T232M (p.Thr232Met), rs775466195, gnomAD 11-128484993-G-A, REVEL 0.20, MetaLR 0.28
- P233P (p.Pro233Pro), rs1221167566, gnomAD 11-128484935-G-C, CADD 8.09
- P233H (p.Pro233His), gnomAD 11-128484936-G-T, REVEL 0.16, MetaLR 0.30
- P233L (p.Pro233Leu), rs747334621, gnomAD 11-128484936-G-A, REVEL 0.21, MetaLR 0.19
- P233A (p.Pro233Ala), rs865964382, gnomAD 11-128484937-G-C, REVEL 0.10, MetaLR 0.14
- P233R (p.Pro233Arg), rs540929701, gnomAD 11-128484984-G-C, REVEL 0.29, AlphaMissense 0.62
- D234Y (p.Asp234Tyr), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60093, Variant assessed as somatic; moderate impact.
- N235S (p.Asn235Ser), cosmic curated COSV60095, ExAC rs779218558, gnomAD rs779218558
- N235K (p.Asn235Lys), rs1229922877, gnomAD 11-128484944-A-T, REVEL 0.02, MetaLR 0.04
- C237Y (p.Cys237Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- M238I (p.Met238Ile), gnomAD 11-128484839-C-A, REVEL 0.07, MetaLR 0.07
- M238T (p.Met238Thr), gnomAD 11-128484840-A-G, REVEL 0.25, MetaLR 0.06
- M238V (p.Met238Val), rs1309710566, gnomAD 11-128484841-T-C, REVEL 0.14, MetaLR 0.04
- G239E (p.Gly239Glu), cosmic curated COSV10518
- G239R (p.Gly239Arg), cosmic curated COSV10518
- T241I (p.Thr241Ile), NCI-TCGA Cosmic COSV6009, cosmic curated COSV60091, Variant assessed as somatic; moderate impact.
- S242G (p.Ser242Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public ETS1 analysis runs
- ETS1 analysis run — ETS1 (528 variants) — completed 2026-08-20